Log In
BCIQ
Print this Print this
 

Oramed Insulin Capsule (ORMD-0801)

  Manage Alerts
Collapse Summary General Information
Company Oramed Pharmaceuticals Inc.
DescriptionOral capsule formulation of insulin
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes; Treat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$49.5M

$3.0M

$34.5M


 Deals Details
Get a free BioCentury trial today